These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7915391)

  • 1. Rapid two-stage PCR for detecting factor V G1691A mutation.
    Beauchamp NJ; Daly ME; Cooper PC; Preston FE; Peake IR
    Lancet; 1994 Sep; 344(8923):694-5. PubMed ID: 7915391
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thrombosis: factor V G1691A genotyping related to APC resistance as measured by 2 methods.
    Alderborn A; Siegbahn A; Wadelius C
    Eur J Haematol; 1997 Apr; 58(4):229-32. PubMed ID: 9186532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 4. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals.
    Ko YL; Hsu TS; Wu SM; Ko YS; Chang CJ; Wang SM; Chen WJ; Cheng NJ; Kuo CT; Chiang CW; Lee YS
    Hum Genet; 1996 Aug; 98(2):176-7. PubMed ID: 8698336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic discrimination of factor V Leiden using the GeneAmp 5700 Sequence Detection System.
    Monk SE; Duckworth AW; Farrugia J; Copplestone JA; Rule SA
    Thromb Haemost; 2002 Dec; 88(6):1071-2. PubMed ID: 12529765
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenotyping and genotyping of coagulation factor V Leiden.
    Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
    Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of the G1691A mutation of coagulation factor V by PCR-mediated site-directed mutagenesis.
    Guillerm C; Lellouche F; Darnige L; Schandelong A; Geffroy F; Dorval I
    Clin Chem; 1996 Feb; 42(2):329. PubMed ID: 8595733
    [No Abstract]   [Full Text] [Related]  

  • 10. [New DNA diagnostic system for determination and identification of homo- and heterozygote point mutations].
    Patrushev LI; Zykova ES; Kaiushin AL; Korosteleva MD; Miroshnikov AI
    Bioorg Khim; 1998 Mar; 24(3):194-200. PubMed ID: 9612561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes.
    Liu Q; Thorland EC; Heit JA; Sommer SS
    Genome Res; 1997 Apr; 7(4):389-98. PubMed ID: 9110178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford.
    Zehnder JL; Hiraki DD; Jones CD; Gross N; Grumet FC
    Thromb Haemost; 1999 Sep; 82(3):1097-9. PubMed ID: 10494770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.
    Sanders Sevall J
    Mol Cell Probes; 2000 Aug; 14(4):249-53. PubMed ID: 10970729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden.
    Castaman G; Ruggeri M; Tosetto A; Missiaglia E; Rodeghiero F
    Thromb Haemost; 1996 Aug; 76(2):275. PubMed ID: 8865545
    [No Abstract]   [Full Text] [Related]  

  • 16. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.
    van de Locht LT; Kuypers AW; Verbruggen BW; Linssen PC; Nováková IR; Mensink EJ
    Thromb Haemost; 1995 Nov; 74(5):1276-9. PubMed ID: 8607109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of factor V Leiden mutation in Koreans.
    Kim YW; Yoon KY; Park S; Shim YS; Cho HI; Park SS
    Thromb Res; 1997 Apr; 86(2):181-2. PubMed ID: 9175239
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.